A carregar...
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis
BACKGROUND: A nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women and men up to age 45 years in the United States. The cost-effectiveness of HPV vaccination for women and men aged 30 to 45 years in the context of cervical cancer screening practice was evaluated to inform...
Na minha lista:
| Publicado no: | PLoS Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7951902/ https://ncbi.nlm.nih.gov/pubmed/33705382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1003534 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|